Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 998 | 1204 | 1143 | 1010 | 1559 | 2356 |
Fund Return | -0.17% | 20.42% | 14.31% | 0.35% | 9.28% | 8.95% |
Place in category | 274 | 128 | 161 | 208 | 342 | 254 |
% in Category | 43 | 23 | 27 | 45 | 70 | 64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guggenheim Mid Cap Value A | 291.15M | -2.10 | 9.01 | 7.44 | ||
Guggenheim Risk Managed Real Estt I | 259.96M | 8.03 | 0.27 | 7.83 | ||
Guggenheim Variable Funds Series A | 255.61M | 22.71 | 11.08 | 12.94 | ||
Guggenheim Variable Funds Series J | 167.11M | -0.13 | 1.17 | 10.20 | ||
Guggenheim Directional Allocation A | 129.77M | 20.61 | 4.07 | 8.62 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.6B | 18.77 | 5.53 | 12.65 | ||
T. Rowe Price Mid-Cap Growth I | 13.38B | 7.79 | 0.27 | - | ||
T. Rowe Price Mid-Cap Growth | 12.45B | 7.68 | 0.14 | 10.48 | ||
Vanguard Mid-Cap Growth Index Admir | 12.09B | 11.75 | -0.99 | 10.25 | ||
T. Rowe Price New Horizons I | 10.75B | 3.91 | -9.99 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Guggenheim Strategy III | - | 36.50 | - | - | |
Guggenheim Strategy II | - | 34.24 | - | - | |
Russell MidCap Growth Index Total Return | - | 7.95 | - | - | |
Guggenheim Ultra Short Duration Instl | - | 3.28 | - | - | |
United Therapeutics | US91307C1027 | 0.47 | 361.88 | -6.32% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Neutral |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review